NCT00005766View on ClinicalTrials.gov

Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG

Creatinine

Trial Locations (1)

05401

University of Vermont, Burlington

All Listed Sponsors

lead

National Center for Research Resources (NCRR)

NIH